Literature DB >> 25770209

Histone deacetylase 6 (HDAC6) promotes the pro-survival activity of 14-3-3ζ via deacetylation of lysines within the 14-3-3ζ binding pocket.

Jeffrey B Mortenson1, Lisa N Heppler1, Courtney J Banks1, Vajira K Weerasekara1, Matthew D Whited1, Stephen R Piccolo2, William E Johnson3, J Will Thompson4, Joshua L Andersen5.   

Abstract

The phospho-binding protein 14-3-3ζ acts as a signaling hub controlling a network of interacting partners and oncogenic pathways. We show here that lysines within the 14-3-3ζ binding pocket and protein-protein interface can be modified by acetylation. The positive charge on two of these lysines, Lys(49) and Lys(120), is critical for coordinating 14-3-3ζ-phosphoprotein interactions. Through screening, we identified HDAC6 as the Lys(49)/Lys(120) deacetylase. Inhibition of HDAC6 blocks 14-3-3ζ interactions with two well described interacting partners, Bad and AS160, which triggers their dephosphorylation at Ser(112) and Thr(642), respectively. Expression of an acetylation-refractory K49R/K120R mutant of 14-3-3ζ rescues both the HDAC6 inhibitor-induced loss of interaction and Ser(112)/Thr(642) phosphorylation. Furthermore, expression of the K49R/K120R mutant of 14-3-3ζ inhibits the cytotoxicity of HDAC6 inhibition. These data demonstrate a novel role for HDAC6 in controlling 14-3-3ζ binding activity.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  14-3- Protein; Apoptosis; Cell Signaling; Histone Deacetylase 6 (HDAC6); Metabolic Stress; Non-histone Acetylation; Stress

Mesh:

Substances:

Year:  2015        PMID: 25770209      PMCID: PMC4432270          DOI: 10.1074/jbc.M114.607580

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  53 in total

1.  The dimeric versus monomeric status of 14-3-3zeta is controlled by phosphorylation of Ser58 at the dimer interface.

Authors:  Joanna M Woodcock; Jane Murphy; Frank C Stomski; Michael C Berndt; Angel F Lopez
Journal:  J Biol Chem       Date:  2003-07-15       Impact factor: 5.157

2.  Identification of novel 14-3-3ζ interacting proteins by quantitative immunoprecipitation combined with knockdown (QUICK).

Authors:  Feng Ge; Wen-Liang Li; Li-Jun Bi; Sheng-Ce Tao; Zhi-Ping Zhang; Xian-En Zhang
Journal:  J Proteome Res       Date:  2010-09-29       Impact factor: 4.466

Review 3.  The capture of phosphoproteins by 14-3-3 proteins mediates actions of insulin.

Authors:  Shuai Chen; Silvia Synowsky; Michele Tinti; Carol MacKintosh
Journal:  Trends Endocrinol Metab       Date:  2011-08-24       Impact factor: 12.015

4.  Multiple myeloma exhibits novel dependence on GLUT4, GLUT8, and GLUT11: implications for glucose transporter-directed therapy.

Authors:  Samuel K McBrayer; Javelin C Cheng; Seema Singhal; Nancy L Krett; Steven T Rosen; Mala Shanmugam
Journal:  Blood       Date:  2012-03-27       Impact factor: 22.113

5.  Identification of 14-3-3zeta as a protein kinase B/Akt substrate.

Authors:  David W Powell; Madhavi J Rane; Qingdan Chen; Saurabh Singh; Kenneth R McLeish
Journal:  J Biol Chem       Date:  2002-04-15       Impact factor: 5.157

6.  PP1 control of M phase entry exerted through 14-3-3-regulated Cdc25 dephosphorylation.

Authors:  Seth S Margolis; Susan Walsh; Douglas C Weiser; Minoru Yoshida; Shirish Shenolikar; Sally Kornbluth
Journal:  EMBO J       Date:  2003-11-03       Impact factor: 11.598

7.  Loss of GLUT4 induces metabolic reprogramming and impairs viability of breast cancer cells.

Authors:  Pablo Garrido; Fernando G Osorio; Javier Morán; Estefanía Cabello; Ana Alonso; José M P Freije; Celestino González
Journal:  J Cell Physiol       Date:  2015-01       Impact factor: 6.384

8.  Interaction of 14-3-3ζ with microtubule-associated protein tau within Alzheimer's disease neurofibrillary tangles.

Authors:  Hamid Y Qureshi; Tong Li; Ryen MacDonald; Chul Min Cho; Nicole Leclerc; Hemant K Paudel
Journal:  Biochemistry       Date:  2013-09-04       Impact factor: 3.162

9.  Depletion of HDAC6 enhances cisplatin-induced DNA damage and apoptosis in non-small cell lung cancer cells.

Authors:  Lei Wang; Shengyan Xiang; Kendra A Williams; Huiqin Dong; Wenlong Bai; Santo V Nicosia; Saadi Khochbin; Gerold Bepler; Xiaohong Zhang
Journal:  PLoS One       Date:  2012-09-05       Impact factor: 3.240

10.  Expression and phosphorylation of the AS160_v2 splice variant supports GLUT4 activation and the Warburg effect in multiple myeloma.

Authors:  Javelin C Cheng; Samuel K McBrayer; Cristian Coarfa; Sevim Dalva-Aydemir; Preethi H Gunaratne; John D Carpten; Jonathan K Keats; Steven T Rosen; Mala Shanmugam
Journal:  Cancer Metab       Date:  2013-05-29
View more
  12 in total

Review 1.  Regulation and role of post-translational modifications of enhancer of zeste homologue 2 in cancer development.

Authors:  Haiqi Lu; Guangliang Li; Chenyi Zhou; Wei Jin; Xiaoling Qian; Zhuo Wang; Hongming Pan; Hongchuan Jin; Xian Wang
Journal:  Am J Cancer Res       Date:  2016-12-01       Impact factor: 6.166

2.  Acylation of Superoxide Dismutase 1 (SOD1) at K122 Governs SOD1-Mediated Inhibition of Mitochondrial Respiration.

Authors:  Courtney J Banks; Nathan W Rodriguez; Kyle R Gashler; Rushika R Pandya; Jeffrey B Mortenson; Matthew D Whited; Erik J Soderblom; J Will Thompson; M Arthur Moseley; Amit R Reddi; Jeffery S Tessem; Matthew P Torres; Benjamin T Bikman; Joshua L Andersen
Journal:  Mol Cell Biol       Date:  2017-09-26       Impact factor: 4.272

3.  SGK2, 14-3-3, and HUWE1 Cooperate to Control the Localization, Stability, and Function of the Oncoprotein PTOV1.

Authors:  Katie L Pennington; Colten M McEwan; James Woods; Colin M Muir; A G Pramoda Sahankumari; Riley Eastmond; Eranga R Balasooriya; Christina M Egbert; Sandeep Kaur; Tyler Heaton; Katherine K McCormack; Stephen R Piccolo; Manabu Kurokawa; Joshua L Andersen
Journal:  Mol Cancer Res       Date:  2021-10-15       Impact factor: 6.333

Review 4.  The role of post-translational modifications in hearing and deafness.

Authors:  Susana Mateo Sánchez; Stephen D Freeman; Laurence Delacroix; Brigitte Malgrange
Journal:  Cell Mol Life Sci       Date:  2016-05-04       Impact factor: 9.261

5.  Identification of multiple roles for histone acetyltransferase 1 in replication-coupled chromatin assembly.

Authors:  Paula A Agudelo Garcia; Michael E Hoover; Pei Zhang; Prabakaran Nagarajan; Michael A Freitas; Mark R Parthun
Journal:  Nucleic Acids Res       Date:  2017-09-19       Impact factor: 16.971

6.  HDAC6 Inhibition Promotes Transcription Factor EB Activation and Is Protective in Experimental Kidney Disease.

Authors:  Angela S Brijmohan; Sri N Batchu; Syamantak Majumder; Tamadher A Alghamdi; Karina Thieme; Sarah McGaugh; Youan Liu; Suzanne L Advani; Bridgit B Bowskill; M Golam Kabir; Laurette Geldenhuys; Ferhan S Siddiqi; Andrew Advani
Journal:  Front Pharmacol       Date:  2018-02-01       Impact factor: 5.810

7.  FAM65B controls the proliferation of transformed and primary T cells.

Authors:  Jeanne Froehlich; Margaux Versapuech; Laura Megrelis; Quitterie Largeteau; Sylvain Meunier; Corinne Tanchot; Georges Bismuth; Jérôme Delon; Marianne Mangeney
Journal:  Oncotarget       Date:  2016-09-27

Review 8.  The dynamic and stress-adaptive signaling hub of 14-3-3: emerging mechanisms of regulation and context-dependent protein-protein interactions.

Authors:  K L Pennington; T Y Chan; M P Torres; J L Andersen
Journal:  Oncogene       Date:  2018-06-18       Impact factor: 9.867

Review 9.  HDAC6-an Emerging Target Against Chronic Myeloid Leukemia?

Authors:  Hélène Losson; Michael Schnekenburger; Mario Dicato; Marc Diederich
Journal:  Cancers (Basel)       Date:  2020-01-29       Impact factor: 6.639

Review 10.  Post-translational modifications of EZH2 in cancer.

Authors:  Zhongwei Li; Minle Li; Diandian Wang; Pingfu Hou; Xintian Chen; Sufang Chu; Dafei Chai; Junnian Zheng; Jin Bai
Journal:  Cell Biosci       Date:  2020-12-11       Impact factor: 7.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.